Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Bundle Contents 1x Retatrutide 10MG lyophilized powder 1x Melanotan 2 10MG lyophilized powder Each vial independently tested for purity and identity Research Context Retatrutide (LY3437943) is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously
Transparency about the regulatory status of the treatment : A responsible doctor will clearly explain whether a proposed treatment is HSA-approved for its intended use, or whether it constitutes off-label use, and will document informed consent accordingly
This peptide exists in two active forms, GLP-1(7-36) amide and GLP-1(7-37), both of which are functionally equivalent, although the former is more abundant (25-28)
Measurement of beta-hydroxybutyrate in acute hyperketonemia in human brain
Because both estrogen and GLP-1 are known to act on receptors in the hypothalamus, research suggests that both may work through converging signaling pathways to regulate lipid and glucose metabolism
Int J Clin Exp Med (2013) 6(1):115
US$ 21.61
US$ 26.90
US$ 27.84
US$ 24.94
